INHALE THERAPEUTIC SYSTEMS, INC.

INHALE DELIVERS INHALED INSULIN

CUSTOM ADAPTATION, ALTERATION, AND REFORMULATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM AS FINE, DRY PARTICLES;PHARMACEUTICAL PREPARATIONS, CONTAINING INHALED INSULIN, NAMELY, INJECTABLE DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE, DRY PARTICLES TO THE DEEP LUNG FOR USE IN THE PREVENTION AND TREATMENT OF DIABETES;INHALED INSULIN;

INHALE DELIVERS PULMONARY INSULIN

CUSTOM ADAPTATION, ALTERATION, AND REFORMULATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM AS FINE, DRY PARTICLES;PHARMACEUTICAL PREPARATIONS CONTAINING PULMONARY INSULIN NAMELY; INJECTABLE DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE, DRY PARTICLES TO THE DEEP LUNG FOR USE IN THE PREVENTION AND TREATMENT OF DIABETES;PULMONARY INSULIN;

INHALEABLE

CUSTOM ADAPTATION AND ALTERATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM;PHARMACEUTICAL PREPARATIONS, NAMELY; MACRO-MOLECULE DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE, DRY PARTICLES TO THE DEEP LUNG FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OTHERWISE REQUIRING OTHER DRUG DELIVERY MEANS FOR TREATMENT;MEDICAL APPARATUS IN THE NATURE OF A UNIT FOR AEROSOL DRUG DELIVERY TO THE DEEP LUNG OF MACRO-MOLECULE DRUGS AS FINE, DRY PARTICLES;

INHALEABLE INSULIN

CUSTOM ADAPTATION AND ALTERATION OF INSULIN DRUGS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM;PHARMACEUTICAL PREPARATIONS, NAMELY; INSULIN FOR DELIVERY IN AEROSOL FORM AS FINE, DRY PARTICLES TO THE DEEP LUNG FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OTHERWISE REQUIRING OTHER DRUG DELIVERY MEANS FOR TREATMENT;MEDICAL APPARATUS IN THE NATURE OF A UNIT FOR AEROSOL DRUG DELIVERY TO THE DEEP LUNG OF INSULIN AS FINE, DRY PARTICLES;

INHANCE

PHARMACEUTICAL PREPARATIONS FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OF THE PERIPHERAL NERVE, OF THE ADRENERGIC AND CHOLINERGIC RECEPTORS; OF THE SKELETAL AND SMOOTH MUSCLE SYSTEMS, CARDIOVASCULAR SYSTEMS, ENDOCRINE AND HORMONE SYSTEMS, BLOOD CIRCULATORY AND IMMUNOLOGICAL SYSTEMS, OF THE SYNOPTIC AND NEUROEFFECTOR JUNCTIONAL SITES, OF THE REPRODUCTIVE, SKELETAL AND AUTACOID SYSTEMS, THE ALIMENTARY AND EXCRETORY SYSTEMS, AND THE HISTAMINE AND CENTRAL NERVOUS SYSTEMS, IN THE NATURE OF DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE DRY PARTICLES TO THE DEEP LUNG;MEDICAL APPARATUS SOLD EMPTY, IN THE NATURE OF A HAND-HELD INHALER UNIT FOR AEROSOL DRUG DELIVERY TO THE DEEP LUNG OF LARGE AND SMALL MOLECULE DRUGS AS FINE, DRY PARTICLES;

INNOVA

MEDICAL APPARATUS IN THE NATURE OF A HAND-HELD UNIT FOR AEROSOL DRUG DELIVERY TO THE DEEP LUNG OF LARGE AND SMALL MOLECULE DRUGS AS FINE, DRY PARTICLES;

ITS INHALEABLE

CUSTOM ADAPTATION AND ALTERATION OF PHARMACEUTICALS PRODUCED BY OTHERS TO RENDER THEM SUITABLE FOR ADMINISTRATION IN AEROSOL FORM;PHARMACEUTICAL PREPARATIONS, NAMELY; MACRO-MOLECULE DRUGS FOR DELIVERY IN AEROSOL FORM AS FINE, DRY PARTICLES TO THE DEEP LUNG FOR TREATMENT OF DISEASES AND MEDICAL CONDITIONS OTHERWISE REQUIRING OTHER DRUG DELIVERY MEANS FOR TREATMENT;MEDICAL APPARATUS IN THE NATURE OF A UNIT FOR AEROSOL DRUG DELIVERY TO THE DEEP LUNG OF MACRO-MOLECULE DRUGS AS FINE, DRY PARTICLES;

PULMOSOL

Custom adaptation, alteration, and reformulation of pharmaceuticals produced by others to render them suitable for administration in aerosol form as fine, dry particles;

PULMOSPHERE

The drawing is amended to appear as follows: PULMOSPHERE;pharmaceutically active compositions, namely, suspensions used as a drug delivery platform for the administration of drugs to the lungs;PULMONARY ATMOSPHERE;

TRANSJECTOR

TRANS JECTOR;aerosolization dispensing unit used as a component of hand-held medical device for aerosol drug delivery;